secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001493152-23-015385
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma appoints Charles Casamento to board; Alan Urban resigns
--------------------------------------------------------------------

- Charles J. Casamento appointed to board effective May 1, 2023, to fill vacant seat.
- Casamento to serve on Audit, Compensation, and Nominating & Governance committees.
- Alan Urban resigned from board on May 1, 2023, to pursue new career opportunities.
- Casamento has >35 years biopharma experience, formerly CEO of Questcor Pharmaceuticals and Osteologix.
- Casamento currently serves on boards of four NASDAQ-listed biotechs: Eton, First Wave, PaxMedica, Relmada.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315223015385/0001493152-23-015385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315223015385/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-015385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer